The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. to provide pharmaceutical products and medical supplies to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The $6,509,967.70 contract, effective from September 15, 2021 through September 14, 2025, was issued without a set-aside designation.
The contract aims to ensure an uninterrupted supply of various medications such as acetaminophen, ibuprofen, loratadine, cetirizine, meclizine, pseudoephedrine, and other common generic drugs in tablet, capsule, and liquid forms, as well as medical supplies like calamine lotion, nasal sprays, and topical creams. These products will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs to serve the healthcare needs of military personnel, veterans, and other government beneficiaries. The award is based on a pre-solicitation issued by the VA in March 2021, seeking offers for melatonin tablets in different strengths, with the successful vendor required to maintain relevant product certifications throughout the contract period.
Generated 7/26/24, 9:02 AM